Mercado Libre Delivers Another Strong Performance in Q2’25, Reporting $6.8 billion Revenue and $825 million Income from Operations

Mercado Libre Delivers Another Strong Performance in Q2'25, Reporting $6.8 billion Revenue and $825 million Income from Operations GlobeNewswire August 04, 2025 Montevideo, Aug. 04, 2025 (GLOBE NEWSWIRE) — Mercado Libre Delivers Another Strong Performance in Q2'25, reporting $6.8 billion revenue and $825 million income from operations In Commerce, items sold rose 31% YoY driven […]

LM Funding America Announces Second Quarter 2025 Earnings Call for August 14, 2025

LM Funding America Announces Second Quarter 2025 Earnings Call for August 14, 2025 GlobeNewswire August 04, 2025 TAMPA, Fla., Aug. 04, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin mining and technology-based specialty finance company, today announced that it has scheduled its second quarter 2025 earnings

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates GlobeNewswire August 04, 2025 Cellectis to host an Investor R&D Day in New York City on October 16, 2025: Phase 1 dataset and late-stage development strategy for lasme-cel (UCART22) in r/r B-ALL to be presented End-of-Phase 1 meetings with FDA & EMA for lasme-cel (UCART22)

Onco360(R) Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC(TM) (linvoseltamab-gcpt)

Onco360(R) Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC(TM) (linvoseltamab-gcpt) GlobeNewswire August 04, 2025 LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) — Onco360(R), the nation's leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic(TM) (linvoseltamab-gcpt), which has been has granted accelerated approval by the Food

Stride, Inc. Signs Multi-District Agreements to Operate K12-Powered Online School in New Mexico

Stride, Inc. Signs Multi-District Agreements to Operate K12-Powered Online School in New Mexico GlobeNewswire August 04, 2025 RESTON, VA, Aug. 04, 2025 (GLOBE NEWSWIRE) — Stride, Inc. (NYSE: LRN) has now partnered with Chama Valley Independent Schools and Santa Rosa Consolidated Schools, to operate Destinations Career Academy of New Mexico (NMDCA), one of its K12-powered

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease GlobeNewswire August 04, 2025 New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 04, 2025 SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company

Bit Origin Announces Completion of Share Capital Reduction

Bit Origin Announces Completion of Share Capital Reduction GlobeNewswire August 04, 2025 SINGAPORE, Aug. 04, 2025 (GLOBE NEWSWIRE) — Bit Origin Ltd (NASDAQ: BTOG) (“Bit Origin” or the “Company”) today announced that it has completed a reduction of its issued share capital, following the approval by its shareholders and subsequent confirmation by the Grand Court

Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

Shareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action – Contact The Gross Law Firm to Learn More GlobeNewswire August 04, 2025 NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). Shareholders who purchased shares of

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire August 04, 2025 MALVERN, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the

Scroll to Top